Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.

Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.

Item
http://www.wikidata.org/entity/Q36237901
The Therapeutic Effect of Pamidronate on Lethal Avian Influenza A H7N9 Virus Infected Humanized MiceInterferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infectionA Subset of Protective γ9δ2 T Cells Is Activated by Novel Mycobacterial Glycolipid ComponentsVγ9Vδ2-T lymphocytes have impaired antiviral function in small-for-gestational-age and preterm neonates.Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells.Characterization of γδT cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro.Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection.The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development.CD73 Expressed on γδ T Cells Shapes Their Regulatory Effect in Experimental Autoimmune UveitisLoss of Intra-Epithelial Endocervical Gamma Delta (GD) 1 T Cells in HIV-Infected WomenIL-23 receptor expression on γδ T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis.Human Vγ9Vδ2-T cells efficiently kill influenza virus-infected lung alveolar epithelial cells.Human Zika infection induces a reduction of IFN-γ producing CD4 T-cells and a parallel expansion of effector Vδ2 T-cells.Functional Conversion and Dominance of γδ T Subset in Mouse Experimental Autoimmune Uveitis.
P2860

Vgamma9Vdelta2 T cell-mediated non-cytolytic antiviral mechanisms and their potential for cell-based therapy.

Item
http://www.wikidata.org/entity/Q36237901
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@ast
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@en
type
label
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@ast
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@en
prefLabel
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@ast
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Vgamma9Vdelta2 T cell-mediated ...... ential for cell-based therapy.
@en
P2093
P304
P31
P356
10.1016/J.IMLET.2005.06.025
P433
P478
P50
P577
P698